non‐small‐cell lung cancer (NSCLCThis chapter presents a series of case studies with multiple choice question and answers on stage II and III non-small-cell lung cancer (NSCLC). It commences with a disclosure on the management of a patient after undergoing a right upper lobectomy, and ends...
Non-small-cell lung cancer (NSCLC) is one of the most frequent cancer types and is responsible for the majority of cancer-related deaths worldwide. The management of NSCLC has improved considerably, especially in the past 10 years. The systematic screening of populations at risk with low-dose...
Thoracic Malignancy II: Beyond Non-small Cell Lung Cancer Session ID: W6-CCH10 Refresher Course AMA PRA Category 1 Credit™: 1.00 ARRT Category A+ Credits (In-person attendees only): 1.00 Location S402 (Opens in a new tab) Speaker(s):Kristopher W. Cummings, MD; Michelle Segall Ginsberg...
Ipilimumab improves clinical outcomes when combined with nivolumab in metastatic non-small cell lung cancer (NSCLC), but its efficacy and impact on the immune microenvironment in operable NSCLC remain unclear. We report the results of the phase 2 randomi
Surgeons prefer pneumonectomy over lobectomy for non-small cell lung cancer (NSCLC) with hilar (T1N1M0 or T2N1M0) disease. We investigated whether survival of stage-II (N1) NSCLC patients (pts) after lobectomy is inferior to that after pneumonectomy and whether tumor histology affects survival....
针对PD-1(programmed cell death-1)的单克隆抗体。它阻断了PD-1及其配体(PD-L1, PD-L2)的相互作用。恢复细胞因子分泌和T细胞活性。它适用于转移性鳞状细胞和非鳞状细胞(包括腺瘤)的非小细胞肺癌、或病情进展或基于铂的化疗后。 Pembrolizumab(Keytruda) ...
Surgical treatment of the non-small cell lung cancer: Stage I (T1N0-T2N0) and stage II (T1N1-T2N1). Prognostic factors, results and recurrence - Lung Cancerdoi:10.1016/0169-5002(94)92245-4NoneLung Cancer
Non-small cell lung cancer; Operation; Evidence-based treatment DOI: 10.7507/1672-2531.20090242 Export PDF Favorites Scan Get Citation Shared Abstract Figures/Tables References Cited by Objective To report evidence-based treatment for 2 case of Ⅱ B stage non-small cell lung cancer. Method...
Rowell NP,Williams CJ.Radical radiotherapy for stage I/II non-small cell lungcancer in patients not sufficiently fit for or declining surgery (medically... NP Rowell,Sevitt - 《Lung Cancer》 被引量: 160发表: 2000年 Radical radiotherapy for stage I/II non-small cell lung cancer inpatients no...
In an ongoing, open-label, single-arm phase II study ( NCT02927301 ), 181 patients with untreated, resectable, stage IB–IIIB non-small cell lung cancer received two doses of neoadjuvant atezolizumab monotherapy. The primary end point was major pathologi